On March 10, The medical seminar entitled “New Hope, New Life” was successfully in Manila, the Philippines. Prof. Peng introduced the cutting-edge minimally invasive therapy, which is of smaller trauma, better efficacy, quicker recovery and fewer side effects, compared with traditional surgery, chemotherapy and radiotherapy. The seminar attracted not only hundreds of patients but also multiple media. News about the symposium was respectively published on World News, Chinese Commercial News, Philippine Chinese Daily.
The medical seminar entitled “New Hope, New Life”
The seminar aims at enhancing the Phlippine-China connection and cooperation in medical field and make joint effort to help more cancer patients. St. Stamford MCHG’ s chief physician and director of the Department of Oncology, Professor Xiaochi Peng said: “the current treatment of tumors has become increasingly inclined to the minimally invasive combined treatment, a number of minimally invasive treatment technology combined with traditional surgery, radiotherapy and chemotherapy has become a new concept of cancer treatment. Our hospital offers Nanoknife Treatment, 3D printing template assisted seed implantation, intra-arterial interventional therapy, Argon Helium Cryotherapy and so on. These are now the internationally acknowledged treatment of tumors and considered as more advanced micro-innovation technology. The minimally invasive techniques has no side effects and very effective. Through its clinical use in recent years, it has become primary choice of treatment for many advanced staged cancer.
Report of seminar on World News, Chinese Commercial News, Philippine Chinese Daily
During the seminar, Professor Xiaochi Peng shared the latest cancer treatments to the patients. After the seminar, meeting lots of patients attended the lecture, Professor Xiaochi Peng said that with the Multidisplinary Team (MDT), he will do his best to treat and help the cancer patients.
On the scene
St. Stamford Modern Cancer Hospital Guangzhou was established since 2005. Since the hospital has officially announces its joint partnership with Singapore Perennial Group in the year 2015, the hospital became China's first joint venture American JCI certified hospital. With more than 12 years in existence, the hospital has introduced cutting-edge minimally invasive equipment from international countries such as US, Germany and others.
Nearly average of 3000 patients underwent minimally invasive treatment every year. It has become one of the most prominent hospitals in the field of treating cancers. The hospital already has 10 satellite offices across Southeast Asian countries, such as Vietnam, Indonesia, Thailand, Philippines and Malaysia.
Through in-depth communication and cooperation in medical research, the Seminar will lead to a new era of cancer techonology for the Phlippines and China.